NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that it has entered into an agreement to sell its poultry vaccines business to Lohmann Animal Health International (Lohmann). Since 2002, Lohmann has performed all manufacturing, marketing and distribution activities for Celldex’s marketed Megan®Vac 1 and Megan®Egg poultry vaccines and has paid Celldex product royalties. Financial terms of the transaction were not disclosed.
